XML 52 R26.htm IDEA: XBRL DOCUMENT v3.22.4

Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2022

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

Segment Net Sales
MedSurg and Neurotechnology:			2022						2021						2020
Instruments			$	2,279					$	2,111					$	1,863
Endoscopy			2,423						2,141						1,763
Medical			3,031						2,607						2,524
Neurovascular			1,200						1,188						973
Neuro Cranial			1,376						1,214						972
Other			302						277						250
			$	10,611					$	9,538					$	8,345
Orthopaedics and Spine:
Knees			$	1,997					$	1,848					$	1,567
Hips			1,413						1,342						1,206
Trauma and Extremities			2,807						2,664						1,722
Spine			1,146						1,167						1,047
Other			475						549						464
			$	7,838					$	7,570					$	6,006
Total			$	18,449					$	17,108					$	14,351

United States Net Sales
MedSurg and Neurotechnology:			2022						2021						2020
Instruments			$	1,810					$	1,637					$	1,471
Endoscopy			1,914						1,670						1,408
Medical			2,422						2,007						1,910
Neurovascular			446						451						381
Neuro Cranial			1,135						988						801
Other			297						273						247
			$	8,024					$	7,026					$	6,218
Orthopaedics and Spine:
Knees			$	1,493					$	1,351					$	1,170
Hips			896						822						777
Trauma and Extremities			2,035						1,866						1,139
Spine			836						831						764
Other			354						425						387
			$	5,614					$	5,295					$	4,237
Total			$	13,638					$	12,321					$	10,455

International Net Sales
MedSurg and Neurotechnology:			2022						2021						2020
Instruments			$	469					$	474					$	392
Endoscopy			509						471						355
Medical			609						600						614
Neurovascular			754						737						592
Neuro Cranial			241						226						171
Other			5						4						3
			$	2,587					$	2,512					$	2,127
Orthopaedics and Spine:
Knees			$	504					$	497					$	397
Hips			517						520						429
Trauma and Extremities			772						798						583
Spine			310						336						283
Other			121						124						77
			$	2,224					$	2,275					$	1,769
Total			$	4,811					$	4,787					$	3,896

Changes in Contract Liabilities

Changes in contract liabilities during the year were as follows:

			2022
Beginning contract liabilities			$	529
Revenue recognized from beginning of year contract liabilities			(329)
Contract liabilities acquired			80
Net advance consideration received during the period			461
Ending contract liabilities			$	741

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration